GlobeNewswire

SolarWinds Showcases Network Management Portfolio Breakthroughs at Cisco Live 2018

Dela

Network Insight(TM) for Cisco Nexus® simplifies the management of complex networks, while intelligent mapping supports hybrid IT environments four times larger than previous generation

AUSTIN, Texas, June 11, 2018 (GLOBE NEWSWIRE) -- SolarWinds, a worldwide leader in network management software, today announced its participation at Cisco Live!®, June 10-14, 2018, in Orlando, Florida. For the first time, the company will publicly exhibit the latest updates to its network management product portfolio, demonstrating the ability to support networks up to four times larger than the previous generation, and how deeper visibility helps IT professionals scale up and support larger data center networks as workloads increase, or scale out to address complex distributed networks. SolarWinds believes the broad refresh, built on the Orion® Platform, strengthens its IDC®-validated network management leadership position.1

"Time is a critical company asset that is becoming increasingly more challenging to manage in a hybrid IT environment," said Christoph Pfister, executive vice president of products, SolarWinds. "Our goal is to arm technology professionals with the right tools, regardless of the size of their organization, so they are able to do more with less-identify problems more quickly and solve network issues with fewer resources, so that eventually they have enough breathing room to take the necessary steps to optimize performance and scale up and out when they are ready."

"In the past, we have been using over 12 different items to track our inventory, to manage our systems, to see how the network is overall performing, and it got to be a pain to know which one to go to, what spreadsheet to even go to," said Allen Gray, senior network engineer, Cooper Standard Automotive, a leading global supplier of systems and components for the automotive industry. "It has saved me time, made us more efficient in our operations, to be able to do other things, and be more proactive versus reactive." Watch video here.

Think Tank Session and In-Booth Presentations

Attendees will have the opportunity to participate in sessions hosted by SolarWinds Head Geeks(TM) Patrick Hubbard, Destiny Bertucci, and Leon Adato at booth 1259, where fully licensed copies of SolarWinds Network Performance Monitor Network Configuration Manager NetFlow Traffic Analyzer Server & Application Monitor and Log Manager for Orion will be given away to qualifying attendees, while supplies last.

Network Ops: Bigger and Badder

  • Who: Patrick Hubbard
  • What: This Think Tank session covers how SolarWinds continues to meet the challenges of expanding monitoring demands. Learn best practices developed by some of the most advanced of SolarWinds' 250,000 customers on how to maintain-or even recover-observability as networks simultaneously grow larger and more complex, while demanding more specialized tools.
  • When:
    · Monday, June 11, 6:30 p.m. - 7:00 p.m. EDT
  • Where: World of Solutions, Think Tank #2
  • Booth 1259 Presentations:
    · Monday, June 11, 11:00 a.m. -  11:30 a.m. EDT
    · Tuesday, June 12, 3:00 p.m. - 3:30 p.m. EDT
    · Wednesday, June 13, 2:00 p.m. - 2:30 p.m. EDT
    · Thursday, June 14, 11:00 a.m. - 11:30 a.m. EDT

Network Insight Expanded: Tame the Most Complex Technologies on Your Network

  • Who: Destiny Bertucci
  • What: Learn how to dig into new hardware details and make troubleshooting easier in this discussion on extracting deep insight from your F5® BIG-IP® load balancers, Cisco® ASAs, and Cisco Nexus NX-OS VDC capable devices.
  • When:
    · Monday, June 11, 3:00 p.m. - 3:30 p.m. EDT
    · Tuesday, June 12, 2:00 p.m. - 2:30 p.m. EDT
    · Wednesday, June 13, 3:00 p.m. - 3:30 p.m. EDT
  • Where: Booth 1259

Solving for Scalability: Design Techniques for Growing Networks and the Monit oring Tools That Love Them

  • Who: Leon Adato
  • What: Remember when your network was little? Of course you don't; it was never little! Gain valuable insight about how to leverage your existing monitoring tools to scale for the technological challenges of tomorrow.
  • When:
    · Monday, June 11, 2:00 p.m. - 2:30 p.m. EDT
    · Tuesday, June 12, 11:00 a.m. - 11:30 a.m. EDT
    · Wednesday, June 13, 11:00 a.m. - 11:30 a.m. EDT
  • Where: Booth 1259

New Versions across the Network Management Portfolio

Within its network management portfolio, SolarWinds announced updates to the following software products.

  • Network Performance Monitor (NPM) 12.3 - Along with Network Insight for Cisco Nexus, including detailed visibility into virtual port channels (vPCs), the latest version of NPM provides superior network monitoring capabilities and detailed visibility for multi-vendor environments.
     
  • Network Configuration Monitor (NCM) 7.8 - The updated version brings even stronger automation and control of network functions and, like NPM, adds Network Insight for Cisco Nexus switches. It provides configuration snippets and the ability to filter, search, and view access control lists (ACLs), including object groups, and virtual device context (VDC) support. 
     
  • IP Address Manager (IPAM) 4.7 - A valuable tool that automates management of IP addresses, the latest version now automates IP requests and monitors hybrid environments with Amazon® Route53 and Azure® DNS support.
     
  • NetFlow Traffic Analyzer (NTA) 4.4 - With a new Flow Storage SQL database at its foundation and less-demanding CPU and IOPS requirements, the new version offers IT professionals significantly improved speed and performance in identifying network traffic issues and removing bottlenecks, while providing better security.
     
  • VoIP & Network Quality Manager (VNQM) 4.5 - The latest version of VNQM adds support for monitoring of SIP trunks, enabling users to manage voice quality and performance across networks using the latest VoIP technologies.

Additional Resources

Connect with SolarWinds

1 Source: IDC-defined Network Management Software functional market. IDC's Worldwide Semiannual Software Tracker®, April 2018

About SolarWinds

SolarWinds provides powerful and affordable IT management software to customers worldwide, from Fortune 500® enterprises to small businesses, managed service providers (MSPs), government agencies, and educational institutions. We are committed to focusing exclusively on IT, MSP, and DevOps professionals, and strive to eliminate the complexity that our customers have been forced to accept from traditional enterprise software vendors. Regardless of where the IT asset or user sits, SolarWinds delivers products that are easy to find, buy, use, maintain, and scale while providing the power to address key areas of the infrastructure from on-premises to the cloud. This focus and commitment to excellence in end-to-end hybrid IT performance management has established SolarWinds as a worldwide leader in both network management software and MSP solutions. Our solutions are rooted in our deep connection to our user base, which interacts in our THWACK online community to solve problems, share technology and best practices, and directly participate in our product development process. Learn more today at www.solarwinds.com.

The SolarWinds, SolarWinds & Design, Orion, and THWACK trademarks are the exclusive property of SolarWinds Worldwide, LLC or its affiliates, are registered with the U.S. Patent and Trademark Office, and may be registered or pending registration in other countries. All other SolarWinds trademarks, service marks, and logos may be common law marks or are registered or pending registration. All other trademarks mentioned herein are used for identification purposes only and are trademarks of (and may be registered trademarks of) their respective companies.

© 2018 SolarWinds Worldwide, LLC. All rights reserved.

MEDIA CONTACTS:
Nicole Fachet
Text100
Phone: 212.871.3950
NicoleF@text100.com

Alex Navarro
SolarWinds
Phone: 512.498.6388
pr@solarwinds.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: SolarWinds Worldwide, LLC via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Immunicum AB (publ) Announces Upcoming Investor Events in October and November22.10.2018 16:00Pressmeddelande

Press Release 22 October 2018 Immunicum AB (publ) Announces Upcoming Investor Events in October and November Immunicum AB (publ; IMMU.ST) announced today that the Company will participate in and host investor events in October and November. At all events Carlos de Sousa, CEO of Immunicum, and other members of the management team, will provide a corporate presentation and be available for a question and answer session. BioStock Life Science Summit Date: October 25, 2018 Presentation Time: 18.50 Central European Time Venue: Medicon Village, Scheelevägen 2, Building 302-auditorium, Lund, Sweden Registration Link: https://www.eventbrite.com/e/biostock-life-science-summit-tickets-51114333347 Immunicum Investor Event - Gothenburg Date: October 29, 2018 Presentation Time: 17.30 - 20.00 Central European Time Venue: First Hotel G, Nils Ericsonplatsen, 411 03 Gothenburg, Sweden Immunicum Investor Event - Stockholm Date: October 30, 2018 Presentation Time: 17.30 - 20.00 Central European Time Venu

Immunicum AB (publ) meddelar kommande investerarevent under oktober och november22.10.2018 16:00Pressmeddelande

Pressmeddelande 22 oktober 2018 Immunicum AB (publ) meddelar kommande investerarevent under oktober och november Immunicum AB (publ; IMMU.ST) meddelar i dag att bolaget kommer att anordna och delta i investerarträffar under oktober och november. Vid samtliga event kommer Carlos de Sousa, Immunicums VD, och övriga medlemmar av ledningsgruppen, att hålla en presentation av bolaget och vara tillgängliga för att svara på frågor. BioStock Life Science Summit Datum: 25 oktober 2018 Presentationstid: Kl. 18.50 CET Plats: Medicon Village, Scheelevägen 2, byggnad 302 - hörsalen, Lund Länk för registrering: https://www.eventbrite.com/e/biostock-life-science-summit-tickets-51114333347 Immunicums investerarevent - Göteborg Datum: 29 oktober 2018 Presentationstid: Kl. 17.30 - 20.00 CET Plats: First Hotel G, Nils Ericsonplatsen, 411 03, Göteborg Immunicums investerarevent - Stockholm Datum: 30 oktober 2018 Presentationstid: Kl. 17.30 - 20.00 CET Plats: Ingenjörshuset Citykonferensen, Plan 1, Malmski

Immunicum AB (publ) presenterar prekliniska resultat för ilixadencel i kombination med checkpointhämmare och immunaktiverare på 2018 års ESMO-kongress22.10.2018 12:45Pressmeddelande

Pressmeddelande 22 oktober 2018 Immunicum AB (publ) presenterar prekliniska resultat för ilixadencel i kombination med checkpointhämmare och immunaktiverare på 2018 års ESMO-kongress -- Intratumoral behandling med ilixadencel, en cellbaserad, lagringsbar immunaktiverare, ger en synergistisk antitumöreffekt och förstärker effekten av behandling med anti-PD-1 och anti-CD137 i djurmodeller -- Immunicum AB (publ; IMMU.ST) presenterar under 2018 års ESMO kongress (European Society for Medical Oncology) prekliniska resultat som visar en synergistisk anti-tumöreffekt när bolagets ledande produkt ilixadencel ges i kombination med en checkpointhämmare eller immunaktiverare. Resultaten från studien, som presenteras på en poster, visar att intratumoralt administrerat ilixadencel kan förstärka anti-tumörsvar och överlevnad vid behandling med checkpointhämmare eller immunaktiverare. Detta visar på potentialen hos ilixadencel att bli en komplementerande verkningsmekanism till flera olika framtida im

Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 201822.10.2018 12:45Pressmeddelande

Press Release 22 October 2018 Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 2018 -- Intratumoral treatment with ilixadencel, an off-the-shelf cell-based immune primer, provides synergistic anti-tumor effect and enhances efficacy of anti-PD-1 and anti-CD137 treatment in animal model -- Immunicum AB (publ; IMMU.ST) announced today the presentation of preclinical results that showed anti-tumor synergy between its lead product ilixadencel and a checkpoint inhibitor or an immune enhancer in a poster at the European Society for Medical Oncology (ESMO) 2018 Congress. The results of the study highlight the ability of intratumoral ilixadencel to enhance anti-tumor response and survival of systemic checkpoint inhibitors (anti-PD-1) or immune enhancers (anti-CD137/4-1BB). This emphasizes the potential for ilixadencel in multiple future immuno-oncology combination strategies by incorporating complementary mech

Karolinska Development's portfolio company OssDsign announces FDA clearance for Cranioplug22.10.2018 09:00Pressmeddelande

STOCKHOLM, October 22, 2018. Karolinska Development's portfolio company OssDsign announces that its latest product Cranioplug has received 510(k) clearance by the FDA, which allows marketing and sales of the product in US. The implant is the first product of its kind in the US market. Cranioplug is an implant used during neurosurgical procedures. The product is intended to cover and plug holes drilled into the skull during surgery and to reattach cranial bone removed during surgery. Cranioplug resorbs and is replaced with bone during the healing process. Anders Lundqvist, CEO of OssDsign, said: "Receiving clearance for Cranioplug is an important step for OssDsign. This motivates us to increase our presence in the US market and continue to build our US organization throughout 2018 and beyond. The regenerative features of OssDsign's calcium phosphate composition are now getting recognized, and it's our mission to turn them into real benefits for patients, surgeons and hospital systems."

Karolinska Development's portfolio company OssDsign announces FDA clearance for Cranioplug22.10.2018 09:00Pressmeddelande

STOCKHOLM, October 22, 2018. Karolinska Development's portfolio company OssDsign announces that its latest product Cranioplug has received 510(k) clearance by the FDA, which allows marketing and sales of the product in US. The implant is the first product of its kind in the US market. Cranioplug is an implant used during neurosurgical procedures. The product is intended to cover and plug holes drilled into the skull during surgery and to reattach cranial bone removed during surgery. Cranioplug resorbs and is replaced with bone during the healing process. Anders Lundqvist, CEO of OssDsign, said: "Receiving clearance for Cranioplug is an important step for OssDsign. This motivates us to increase our presence in the US market and continue to build our US organization throughout 2018 and beyond. The regenerative features of OssDsign's calcium phosphate composition are now getting recognized, and it's our mission to turn them into real benefits for patients, surgeons and hospital systems."

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum